UA94954C2 - Застосування есцину для лікування хвороби, походження якої опосередковане або викликане активованими гранулоцитами - Google Patents

Застосування есцину для лікування хвороби, походження якої опосередковане або викликане активованими гранулоцитами

Info

Publication number
UA94954C2
UA94954C2 UAA200900868A UAA200900868A UA94954C2 UA 94954 C2 UA94954 C2 UA 94954C2 UA A200900868 A UAA200900868 A UA A200900868A UA A200900868 A UAA200900868 A UA A200900868A UA 94954 C2 UA94954 C2 UA 94954C2
Authority
UA
Ukraine
Prior art keywords
escin
caused
treatment
diseases mediated
activated granulocytes
Prior art date
Application number
UAA200900868A
Other languages
English (en)
Russian (ru)
Inventor
Андреас Грассауер
Єва Прішл
Original Assignee
Маріномед Біотехнологі Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Маріномед Біотехнологі Гмбх filed Critical Маріномед Біотехнологі Гмбх
Publication of UA94954C2 publication Critical patent/UA94954C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)

Abstract

Даний винахід стосується застосування есцину для виготовлення фармацевтичного препарату для лікування хвороби, походження якої опосередковане або викликане активованими гранулоцитами.
UAA200900868A 2006-08-04 2007-08-03 Застосування есцину для лікування хвороби, походження якої опосередковане або викликане активованими гранулоцитами UA94954C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06450109A EP1884245A1 (en) 2006-08-04 2006-08-04 Use of Escin
PCT/EP2007/006870 WO2008015007A2 (en) 2006-08-04 2007-08-03 Use of escin

Publications (1)

Publication Number Publication Date
UA94954C2 true UA94954C2 (uk) 2011-06-25

Family

ID=37969918

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200900868A UA94954C2 (uk) 2006-08-04 2007-08-03 Застосування есцину для лікування хвороби, походження якої опосередковане або викликане активованими гранулоцитами

Country Status (21)

Country Link
US (2) US20100227830A1 (uk)
EP (2) EP1884245A1 (uk)
JP (1) JP5345933B2 (uk)
KR (1) KR20090034946A (uk)
CN (1) CN101500582B (uk)
AU (1) AU2007280625B2 (uk)
BR (1) BRPI0715070B8 (uk)
CA (1) CA2658279C (uk)
DK (1) DK2046345T3 (uk)
EA (1) EA015404B1 (uk)
ES (1) ES2531516T3 (uk)
HR (1) HRP20141243T1 (uk)
IL (1) IL196606A (uk)
MX (1) MX2009000991A (uk)
NZ (1) NZ574249A (uk)
PL (1) PL2046345T3 (uk)
PT (1) PT2046345E (uk)
SI (1) SI2046345T1 (uk)
UA (1) UA94954C2 (uk)
WO (1) WO2008015007A2 (uk)
ZA (1) ZA200900372B (uk)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2303287T3 (en) * 2008-07-01 2014-02-17 Marinomed Biotechnologie Gmbh Antiallergic marine biopolymers
EP2186523A1 (en) * 2008-11-18 2010-05-19 Marinomed Biotechnologie GmbH Use of escin for treatment of Type IV hypersensitivity reaction
ES2346844B1 (es) * 2010-03-17 2011-08-09 Ricardo Lombardero Calzon Crema para quemaduras.
WO2012101618A1 (en) 2011-01-28 2012-08-02 Barcelcom Têxteis S.A. Compression stockings and tubes with bioactive agents for the treatment of venous insufficiency and varicose veins
WO2014150545A1 (en) 2013-03-15 2014-09-25 Mary Kay Inc. Cosmetic compositions and uses thereof
US9801900B2 (en) 2013-11-22 2017-10-31 Mary Kay Inc. Compositions for sensitive skin
CN104147055A (zh) * 2014-07-08 2014-11-19 武汉爱民制药有限公司 赖氨酸七叶皂苷及其盐在制备治疗i型超敏反应药物中的用途
US20180154777A1 (en) * 2016-12-02 2018-06-07 Faraday&Future Inc. Braking torque blending system and method for automatic emergency braking
IT202100014495A1 (it) * 2021-06-08 2022-12-08 Neilos S R L "Composizione per l’uso nella prevenzione e/o nel trattamento di patologie osteoarticolari"

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1676561U (de) 1954-03-27 1954-05-20 Lutz Kg Maschf Eugen Vorrichtung zum fraesen von nuten u. dgl. mittels einer motor-oberfraese.
DE3402259A1 (de) * 1984-01-24 1985-08-01 Stephan Dr.med. 3000 Hannover Regöczy Therapeutisch wirksames gemisch, insbesondere zur behandlung von infektionskrankheiten im hals-, nasen- ohrenbereich, stimmbandentzuendungen, schwerer heiserkeit und trombophlebitis
DE3445324A1 (de) * 1984-12-12 1986-06-12 Klinge Pharma GmbH, 8000 München Arzneimittelkombination mit synergistischer wirkung
IT1252866B (it) 1991-12-31 1995-06-28 Lifegroup Spa N-acilderivati di aminoalcooli con acidi policarbossilici atti alla modulazione dei mastociti nei processi infiammatori su base neuroimmunogenica
US6894146B1 (en) * 1997-02-25 2005-05-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6943236B2 (en) * 1997-02-25 2005-09-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7033827B2 (en) * 1997-02-25 2006-04-25 Corixa Corporation Prostate-specific polynucleotide compositions
US6800746B2 (en) * 1997-02-25 2004-10-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6630305B1 (en) * 1999-11-12 2003-10-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6759515B1 (en) * 1997-02-25 2004-07-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7049063B2 (en) * 1998-03-18 2006-05-23 Corixa Corporation Methods for diagnosis of lung cancer
US6509448B2 (en) * 1999-06-30 2003-01-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6504010B1 (en) * 1999-06-30 2003-01-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6858204B2 (en) * 1999-06-30 2005-02-22 Corxia Corporation Compositions and methods for the therapy and diagnosis of lung cancer

Also Published As

Publication number Publication date
CA2658279A1 (en) 2008-02-07
SI2046345T1 (sl) 2015-03-31
MX2009000991A (es) 2009-04-16
US9993512B2 (en) 2018-06-12
JP2009545623A (ja) 2009-12-24
NZ574249A (en) 2011-04-29
BRPI0715070B1 (pt) 2021-04-13
EA200900261A1 (ru) 2009-06-30
PT2046345E (pt) 2014-12-26
BRPI0715070B8 (pt) 2021-05-25
EP1884245A1 (en) 2008-02-06
WO2008015007A2 (en) 2008-02-07
HRP20141243T1 (hr) 2015-02-13
ZA200900372B (en) 2009-12-30
PL2046345T3 (pl) 2015-05-29
EP2046345B1 (en) 2014-12-10
US20170014465A1 (en) 2017-01-19
BRPI0715070A2 (pt) 2013-06-25
CN101500582A (zh) 2009-08-05
AU2007280625A1 (en) 2008-02-07
JP5345933B2 (ja) 2013-11-20
WO2008015007A3 (en) 2008-04-03
EA015404B1 (ru) 2011-08-30
KR20090034946A (ko) 2009-04-08
ES2531516T3 (es) 2015-03-16
AU2007280625B2 (en) 2012-05-17
IL196606A (en) 2015-08-31
DK2046345T3 (en) 2015-01-26
CN101500582B (zh) 2011-08-24
EP2046345A2 (en) 2009-04-15
IL196606A0 (en) 2009-11-18
US20100227830A1 (en) 2010-09-09
CA2658279C (en) 2014-10-28

Similar Documents

Publication Publication Date Title
MX2009000991A (es) Uso de escina.
IN2012DN02805A (uk)
WO2009036175A3 (en) F1f0-atpase inhibitors and related methods
MX2010002312A (es) Compuestos de triazolopiridina y su uso como inhibidores de cinasa reguladora de señal de apoptosis.
WO2008127364A3 (en) Antiviral compounds and use thereof
MX2009006704A (es) Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa.
TW200716646A (en) (S)-N-methylnaltrexone
UA108198C2 (uk) Заміщені 2-ацетамідо-5-арил-1,2,4-триазолони та їх застосування
LT2878297T (lt) Medikamentai, skirti fibrozinių ligų gydymui arba prevencijai
IN2012DN00971A (uk)
TW200740844A (en) Novel MAdCAM antibodies
MY145349A (en) Benzofuro- and benzothienopyrimidine modulators of the histamine h4 receptor
WO2008046581A3 (de) Substituierte tetrahydropyrrolopyrazin-verbindungen als inhibitoren der monoaminwiederaufnahme und deren verwendung in arzeimitteln
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
JO2645B1 (en) Vehicles
WO2009071689A3 (de) 5-halogen-substituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen
TW200745043A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
WO2009124962A3 (en) Sulfonamides
UA97401C2 (uk) Екструдат з поліпшеним маскуванням смаку
MX2009001315A (es) Compuestos de dimetilciclobutilo substituidos, su preparación y uso en medicamentos.
SI1940409T1 (sl) Nove zdravilske kombinacije za zdravljenje bolezni dihalnih poti
WO2007115929A8 (de) Thiazolyl-dihydro-quinazoline
UA96476C2 (uk) Фармацевтичні композиції, що містять ірбесартан
UA94781C2 (uk) Застосування йота-карагенану для профілактики або терапевтичного лікування риновірусної інфекції
UA96574C2 (uk) Використання івабрадину для одержання ліків, призначених для лікування ендотеліальної дисфункції